Chronic Pain

Chronic Pain Program

Chronic-Pain-Eupraxia-PharmaChronic pain affects an estimated 1.5 billion individuals worldwide and is one of the hardest conditions to treat. More than 11 million Americans last year turned to off-label use of medications to treat their chronic pain. This type of medication provides relief for only a short period of time and can put patients at risk of complications.

Our chronic pain product candidate, EP-104EPI, is a non-opioid, locally administered, sustained release compound that aims to provide extended pain relief while reducing potential complications. Our first target is back pain – one of the most prevalent areas requiring chronic pain medication.